首 页
医药产品
医保药品
中标目录
医药招标
数据中心
医学资料
医药新闻
医药展会
OTC药品
保健品
医疗器械
处方药
专科药
中医药
器械中标目录
药品批发行情
求购信息
医药下载
药价简讯
当前位置:药药网 / 数据中心 / 临床注释-2,变异和临床注释数据
托司琼
临床注释ID
1450929851
药物名称(英)
tropisetron
变异单倍型
CYP2D6*1, CYP2D6*1xN, CYP2D6*2xN
基因
CYP2D6
证据级别
1A
水平覆盖
水平修饰符
Tier 1 VIP
表现型类别(英)
Efficacy
表现型类别
功效
分数
103.25
PMID计数
1
计数的证据
2
表现型
呕吐
表现型(英)
Vomiting
最新日期
2021/3/24 0:00:00
URL
https://www.pharmgkb.org/clinicalAnnotation/1450929851
专业人口(英)
专业人口
临床等位基因
id
等位基因
注释文本
717
*2xN
The CYP2D6*2xN alleles (*2x2 and *2x鈮?) are assigned as increased function alleles by CPIC. Patients carrying a *2xN allele in combination with a normal or increased function allele or a decreased function allele with an activity value of 0.5 may have a decreased response to tropisetron as compared to patients with alleles that result in a normal metabolizer phenotype. Patients carrying a *2xN allele with an activity value of 3 or greater in combination with a decreased function allele with an activity value of 0.25 or a no function allele may also have a decreased response to tropisetron as compared to patients with alleles that result in a normal metabolizer phenotype, while patients carrying a *2xN allele with an activity value of 2 in combination with a decreased function allele with an activity value of 0.25 or a no function allele may have a similar response to tropisetron as compared to patients with alleles that result in a normal metabolizer phenotype. Be aware that the CPIC guideline for tropisetron and CYP2D6 has a 'no recommendation' for CYP2D6 intermediate and poor metabolizers. Other genetic and clinical factors may also influence response to tropisetron.
716
*1xN
The CYP2D6*1xN alleles (*1x2 and *1x鈮?) are assigned as increased function alleles by CPIC. Patients carrying a *1xN allele in combination with a normal or increased function allele or a decreased function allele with an activity value of 0.5 may have a decreased response to tropisetron as compared to patients with alleles that result in a normal metabolizer phenotype. Patients carrying a *1xN allele with an activity value of 3 or greater in combination with a decreased function allele with an activity value of 0.25 or a no function allele may also have a decreased response to tropisetron as compared to patients with alleles that result in a normal metabolizer phenotype, while patients carrying a *1xN allele with an activity value of 2 in combination with a decreased function allele with an activity value of 0.25 or a no function allele may have a similar response to tropisetron as compared to patients with alleles that result in a normal metabolizer phenotype. Be aware that the CPIC guideline for tropisetron and CYP2D6 has a 'no recommendation' for CYP2D6 intermediate and poor metabolizers. Other genetic and clinical factors may also influence response to tropisetron.
715
*1
The CYP2D6*1 allele is assigned as a normal function allele by CPIC. Patients carrying the *1 allele in combination with alleles that result in a normal metabolizer phenotype may have a similar response to tropisetron as compared to patients with two decreased or no function alleles or a no function allele in combination with a normal or decreased function allele, while patients carrying the *1 allele in combination with alleles that result in a normal metabolizer phenotype may have a deceased response to tropisetron as compared to patients with two increased function alleles or an increased function allele in combination with a normal function allele or a deceased function allele with an activity value of 0.5 or patients with an increased function allele with an activity value of 3 or greater in combination with a no function allele or a decreased function allele with an activity value of 0.25. Be aware that the CPIC guideline for tropisetron and CYP2D6 has a 'no recommendation' for CYP2D6 intermediate and poor metabolizers. Other genetic and clinical factors may also influence response to tropisetron.
临床证据
id
证据的ID
总结
325
981954714
CYP2D6 *1/*1xN is associated with decreased response to ondansetron or tropisetron in people with Neoplasms.
324
PA166161955
Annotation of CPIC Guideline for tropisetron and CYP2D6
临床病史
id
类型
评论
997
Update
CA score added as part of scoring system release. LOE assigned following curator review.
996
Update
Minor edits to phenotype descriptions
995
Update
Rewrote phenotype descriptions and added CPIC guideline
994
Update
Allele descriptions. This diverges from the standard sentence given that comparison is UM vs other phenotypes not necessarily only *1
993
Create
Created. LOE = 1A because of CPIC guideline for CYP2D6 and tropisetron.
最新招商产品
更多>>
韩特润目冷敷凝胶贴牌定制代..
济南康民药业..
全国||不限
韩特润目冷敷凝胶贴牌定制代..
济南康民药业..
全国||不限
韩特乳康冷敷凝胶贴牌定制代..
济南康民药业..
全国||不限
韩特筋骨冷敷凝胶贴牌定制代..
济南康民药业..
全国||不限
韩特筋骨冷敷凝胶贴牌定制代..
济南康民药业..
全国||不限
韩特筋骨冷敷凝胶贴牌定制代..
济南康民药业..
全国||不限
韩特筋骨医用冷敷贴贴牌定制..
济南康民药业..
全国||不限
韩特筋骨医用冷敷贴贴牌定制..
济南康民药业..
全国||不限
韩特前列腺冷敷凝胶贴牌定制..
济南康民药业..
全国||不限
韩特前列腺医用冷敷贴贴牌定..
济南康民药业..
全国||不限
网站地图
-
网站开发
-
网站简介
-
会员服务
-
法律声明
-
联系我们
-
药品招商频道
-
药品信息排行
-
2018年版国家基本药物目录
-
意见反馈
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:
医药研究数据
|
医药资料
|
SDA药品评审中心
|
中医网
|
中药处方系统
|
爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究 客服热线:0575-83552251 / 13754370441 QQ客服:
浙ICP备16010490号-2
增值电信业务经营许可证:
浙B2-20220931
互联网药品信息服务资格证书编号:
(浙)-经营性2023-0215
浙公网安备:330683240604819103159
医药代理商群1:
医药代理商群2:
医药代理商群3: